SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001213900-21-026169
Filing Date
2021-05-14
Accepted
2021-05-13 17:56:04
Documents
14
Period of Report
2021-05-13
Items
Item 2.02: Results of Operations and Financial Condition
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 FORM 8-K ea140818-8k_cormedix.htm   iXBRL 8-K 24977
2 PRESS RELEASE DATED MAY 13, 2021 ea140818ex99-1_cormedix.htm EX-99.1 78733
3 GRAPHIC image_001.jpg GRAPHIC 5628
  Complete submission text file 0001213900-21-026169.txt   293091

Data Files

Seq Description Document Type Size
4 XBRL SCHEMA FILE crmd-20210513.xsd EX-101.SCH 3023
5 XBRL LABEL FILE crmd-20210513_lab.xml EX-101.LAB 34238
6 XBRL PRESENTATION FILE crmd-20210513_pre.xml EX-101.PRE 22357
7 EXTRACTED XBRL INSTANCE DOCUMENT ea140818-8k_cormedix_htm.xml XML 3593
Mailing Address 300 CONNELL DRIVE SUITE 4200 BERKELEY HEIGHTS NJ 07922
Business Address 300 CONNELL DRIVE SUITE 4200 BERKELEY HEIGHTS NJ 07922 908-517-9500
CorMedix Inc. (Filer) CIK: 0001410098 (see all company filings)

IRS No.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-34673 | Film No.: 21921104
SIC: 2834 Pharmaceutical Preparations
Office of Life Sciences